Express News | Sonnet BioTherapeutics Publishes Key Data On SON-1010 IL-12 Fusion Protein In Frontiers In Immunology, Highlighting Mechanism Of Action And Enhanced Tumor Targeting With Patents Secured Through 2039

BenzingaDec 4 09:21 ET

Sonnet BioTherapeutics Releases Virtual Investor '"What This Means" Segment

GlobeNewswireNov 12 09:15 ET

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswireNov 6 13:20 ET

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

BenzingaNov 6 12:47 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaNov 6 11:34 ET

Trending Stocks Today | FOXO Technologies Surges 172.81%

Moomoo NewsNov 6 10:05 ET